Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Shares of Aehr Test Systems AEHR fell sharply during Monday’s session after the company reported preliminary third-quarter and FY24 adjusted EPS and revenue results below estimates.

Aehr reported preliminary third-quarter revenue of $7.6 million and adjusted loss of 3 cents to 4 cents per share, according to data from Benzinga Pro.

Aehr Test System shares tumbled 18.1% to $12.01 on Monday.

Here are some other big stocks recording losses in today’s session.

• Vimeo, Inc. VMEO shares declined 26% to $3.9800.
• Invivyd, Inc. IVVD fell 16.7% to $3.63.
• Canopy Growth Corporation CGC declined 13.1% to $6.68. The German government recently approved legislation which legalizes the possession and cultivation of cannabis beginning April 1.
• Compass Minerals International, Inc. CMP fell 13.1% to $15.25. The US Forest Service halted contract with Compass Minerals for 2024 Fire Season due to safety concerns.
• Yiren Digital Ltd. YRD dipped 12% to $4.46.
• Dyne Therapeutics, Inc. DYN tumbled 11.8% to $24.90 after the company announced a CEO transition.
• Open Lending Corporation LPRO shares declined 10.3% to $6.41. Open Lending named Chuck Jehl as COO and Interim CEO.
• Sera Prognostics, Inc. SERA fell 9.3% to $9.07. The company, last week, posted weak quarterly sales.
• ReposiTrak, Inc. TRAK fell 9.2% to $15.58.
• Critical Metals Corp. CRML dipped 8.5% to $12.26.
• Alvotech ALVO declined 8.1% to $13.74. Alvotech announced an increase in number of own shares.
• Chewy, Inc. CHWY fell 6.7% to $15.49.
• Graphjet Technology GTI fell 6.6% to $8.77.
• United Airlines Holdings, Inc. UAL declined 5.4% to $43.97 after the FAA reportedly weighed curbing new routes for the airline amid recent safety issues.
• Repligen Corporation RGEN fell 4.8% to $188.49.

Now Read This: Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'